Improving Treatment Outcomes of Patients With Waldenstrom Macroglobulinemia
1.0 CME | 1.0 CNE | 1.0 MOC
How can you improve the treatment outcomes for patients with this rare malignancy? This online activity, led by Morie A. Gertz, MD, MACP and Toni Dubeau, RN, NP, will discuss risk stratification, novel therapeutic approaches, and adverse event management. Start now!